SSR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.272200E-01
Normal-vs-Stage2
5.266200E-01
Normal-vs-Stage3
9.232200E-01
Normal-vs-Stage4
5.811800E-01
Stage1-vs-Stage2
6.345400E-01
Stage1-vs-Stage3
8.049800E-01
Stage1-vs-Stage4
6.710600E-01
Stage2-vs-Stage3
5.437800E-01
Stage2-vs-Stage4
9.962600E-01
Stage3-vs-Stage4
6.060000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.249000E-01
Normal-vs-AfricanAmerican
3.592000E-01
Normal-vs-Asian
8.865600E-01
Caucasian-vs-AfricanAmerican
3.377000E-01
Caucasian-vs-Asian
4.836200E-01
AfricanAmerican-vs-Asian
1.658760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.343800E-01
Normal-vs-Female
5.290400E-01
Male-vs-Female
9.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.335200E-01
Normal-vs-Age(41-60Yrs)
3.952200E-01
Normal-vs-Age(61-80Yrs)
6.583400E-01
Normal-vs-Age(81-100Yrs)
7.096400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.631900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.933000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.785400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.078600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.483200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.824000E-01
Normal-vs-Daily Drinker
6.018400E-01
Normal-vs-Weekly Drinker
5.129600E-01
Normal-vs-Occasional Drinker
6.201200E-01
Normal-vs-Social Drinker
4.272400E-01
Non Drinker-vs-Daily Drinker
1.274820E-01
Non Drinker-vs-Weekly Drinker
2.346400E-01
Non Drinker-vs-Occasional Drinker
3.104600E-01
Non Drinker-vs-Social Drinker
1.187220E-01
Daily Drinker-vs-Weekly Drinker
2.713700E-02
Daily Drinker-vs-Occasional Drinker
8.099500E-02
Daily Drinker-vs-Social Drinker
2.622400E-02
Weekly Drinker-vs-Occasional Drinker
8.052400E-01
Weekly Drinker-vs-Social Drinker
4.375400E-01
Occasional Drinker-vs-Social Drinker
6.525200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.587800E-01
Normal-vs-Grade 2
1.745830E-01
Normal-vs-Grade 3
3.112000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.326820E-01
Grade 1-vs-Grade 3
1.611840E-01
Grade 1-vs-Grade 4
6.587800E-01
Grade 2-vs-Grade 3
9.942600E-01
Grade 2-vs-Grade 4
1.745830E-01
Grade 3-vs-Grade 4
3.112000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.014000E-01
Normal-vs-NonDiabetic
6.762800E-01
Diabetic-vs-NonDiabetic
6.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.415400E-01
Normal-vs-NoPancreatitis
6.606000E-01
Pancreatitis-vs-NoPancreatitis
8.763000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.428600E-01
Normal-vs-N1
5.103600E-01
N0-vs-N1
2.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.542400E-01
Normal-vs-TP53-NonMutant
7.287400E-01
TP53-Mutant-vs-TP53-NonMutant
1.480640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
